Anhui, China

Feihu Chen

This inventor holds 1 USPTO granted patent. Top assignees: Anhui Medical University, Anhui New Star Pharmaceutical Development Co., Ltd.. Active years: 2012.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Feihu Chen: Innovator in Pharmaceutical Development

Introduction

Feihu Chen is a notable inventor based in Anhui, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address serious health conditions. His work focuses on innovative solutions for treating various types of tumors and skin disorders.

Latest Patents

Feihu Chen holds a patent for a retinoid derivative and pharmaceutical composition. This invention is designed to prevent or treat hematological tumors, such as acute leukemia, chronic leukemia, multiple myeloma, and lymphoma. Additionally, it addresses solid tumors, including liver cancer, rectal cancer, mammary cancer, and esophagus cancer. The compound is also effective in treating skin disorders like psoriasis and acne. He has 1 patent to his name.

Career Highlights

Throughout his career, Feihu Chen has been associated with prominent institutions such as Anhui Medical University and Anhui New Star Pharmaceutical Development Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the pharmaceutical industry.

Collaborations

Feihu Chen has collaborated with notable colleagues, including Yuan Wang and Jingjing Ruan. These partnerships have played a crucial role in enhancing his research and development efforts.

Conclusion

Feihu Chen's innovative work in pharmaceuticals demonstrates his commitment to improving health outcomes through scientific advancements. His contributions are vital in the ongoing fight against serious medical conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…